Potential modulating effects of micronutrients on prostate specific antigen (PSA) response to androgen deprivation therapy in prostate cancer

被引:0
|
作者
Resh, J
Kannan, S
Wei, JT
Dunn, R
机构
[1] Univ Michigan, Dept Environm Hlth Sci, Nutr Program, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Ctr Med, Dept Urol, Ann Arbor, MI 48109 USA
来源
FASEB JOURNAL | 2002年 / 16卷 / 04期
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:A371 / A371
页数:1
相关论文
共 50 条
  • [1] Prostate Specific Antigen Half-Time and Prostate Specific Antigen Doubling Time as Predictors of Response to Androgen Deprivation Therapy for Metastatic Prostate Cancer
    Park, Yong Hyun
    Hwang, In Sik
    Jeong, Chang Wook
    Kim, Hyeon Hoe
    Lee, Sang Eun
    Kwak, Cheol
    JOURNAL OF UROLOGY, 2009, 181 (06): : 2520 - 2524
  • [2] PROSTATE-SPECIFIC ANTIGEN AND ANDROGEN DEPRIVATION THERAPY
    RUCKLE, HC
    OESTERLING, JE
    WORLD JOURNAL OF UROLOGY, 1993, 11 (04) : 227 - 232
  • [3] Clinical outcomes and nadir prostate-specific antigen (PSA) according to initial PSA levels in primary androgen deprivation therapy for metastatic prostate cancer
    Kitagawa, Yasuhide
    Ueno, Satoru
    Izumi, Kouji
    Kadono, Yoshifumi
    Mizokami, Atsushi
    Hinotsu, Shiro
    Akaza, Hideyuki
    Namiki, Mikio
    WORLD JOURNAL OF UROLOGY, 2016, 34 (03) : 319 - 327
  • [4] Clinical outcomes and nadir prostate-specific antigen (PSA) according to initial PSA levels in primary androgen deprivation therapy for metastatic prostate cancer
    Yasuhide Kitagawa
    Satoru Ueno
    Kouji Izumi
    Yoshifumi Kadono
    Atsushi Mizokami
    Shiro Hinotsu
    Hideyuki Akaza
    Mikio Namiki
    World Journal of Urology, 2016, 34 : 319 - 327
  • [5] Impact of Prostate-Specific Antigen (PSA) Nadir and Time to PSA Nadir on Disease Progression in Prostate Cancer Treated With Androgen-Deprivation Therapy
    Huang, Shu-Pin
    Bao, Bo-Ying
    Wu, Ming-Tsang
    Choueiri, Toni K.
    Goggins, William B.
    Huang, Chao-Yuan
    Pu, Yeong-Shiau
    Yu, Chia-Cheng
    Huang, Chun-Hsiung
    PROSTATE, 2011, 71 (11): : 1189 - 1197
  • [6] Prostate-Specific Antigen Kinetics under Androgen Deprivation Therapy and Prostate Cancer Prognosis
    Zhang, Li-min
    Jiang, Hao-wen
    Tong, Shi-jun
    Zhu, Hui-qing
    Liu, Jun
    Ding, Qiang
    UROLOGIA INTERNATIONALIS, 2013, 91 (01) : 38 - 48
  • [7] Prostate Specific Antigen Half-Time and Prostate Specific Antigen Doubling Time as Predictors of Response to Androgen Deprivation Therapy for Metastatic Prostate Cancer COMMENT
    Cummings, James M.
    JOURNAL OF UROLOGY, 2009, 181 (06): : 2525 - 2525
  • [8] Evaluation of serum values of Chromogranin A in monitoring patients with Prostate cancer under Androgen deprivation therapy. Comparison with Prostate Specific Antigen (PSA).
    Zissimopoulos, A.
    Bantis, A.
    Karathanos, E.
    Touloupides, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 : S239 - S239
  • [9] Discovery of prostate specific antigen pattern to predict castration resistant prostate cancer of androgen deprivation therapy
    Kim, Yejin
    Park, Yong Hyun
    Lee, Ji Youl
    Choi, In Young
    Yu, Hwanjo
    BMC MEDICAL INFORMATICS AND DECISION MAKING, 2016, 16
  • [10] Discovery of prostate specific antigen pattern to predict castration resistant prostate cancer of androgen deprivation therapy
    Yejin Kim
    Yong Hyun Park
    Ji Youl Lee
    In Young Choi
    Hwanjo Yu
    BMC Medical Informatics and Decision Making, 16